Skip to main content
. 2020 May 13;86(10):2080–2094. doi: 10.1111/bcp.14303

TABLE 3.

PBPK model predictions and clinically‐reported pharmacokinetic parameters of midazolam and tacrolimus in the presence and absence of S. sphenanthera extract in healthy people

C max (ng mL−1) a AUC0–24h (ng h−1 mL −1) CL/F (L h−1)
Victim drug alone Along with S. sphenantera Ratio Victim drug alone Along with S. sphenantera Ratio Victim drug alone Along with S. sphenantera Ratio>
Interaction with a single dose of midazolam (15 mg) based on the study by Xin et al. 16 , b
PBPK prediction 138.2 217.1 1.57 551.2 1,117.5 2.03 27.2 13.4 0.49
Clinically‐reported values 171.4 ± 69.8 282.3 ± 152.2 1.65 577.7 ± 226.8 1,185.6 ± 319.8 2.05 30.9 ± 16.7 13.8 ± 5.8 0.45
Prediction fold‐difference c 0.81 0.77 0.95 0.95 0.94 0.99 0.88 0.97 1.09
Interaction with a single dose of tacrolimus (2 mg) based on the study by Xin et al. 18 , d
PBPK prediction 21.5 60.5 2.81 125.2 305.1 2.44 16.0 6.6 0.41
Clinically‐reported values 22.2 ± 10.6 66.4 ± 12.3 2.99 129.5 ± 65.1 274.8 ± 64.9 2.12 17.7 ± 12.6 6.5 ± 1.5 0.37
Prediction fold‐difference 0.97 0.91 0.94 0.97 1.11 1.15 0.90 1.02 1.11

AUC0–24h, area under the plasma concentration‐time curve during 24 h after dose; CL/F, apparent clearance; C max, peak concentration.

a

C max was reported as peak plasma and blood concentrations for midazolam and tacrolimus, respectively.

b

A cross‐over study in healthy Chinese males (n = 12) with age ranged from 21 to 23 years. A single oral dose of midazolam (15 mg) was given with and without S. sphenanthera extract containing schisandrin A (7.25 mg), schisantherin A (7.33 mg) and schisandrol B (0.12 mg) twice daily for 7 days prior to midazolam administration.

c

Prediction‐fold differences were expressed as the ratio of PBPK prediction to clinically‐observed values.

d

A cross‐over study in healthy Chinese males (n = 12) with age ranged from 22 to 25 years. A single oral dose of tacrolimus (2 mg) was given in the presence and absence of S. sphenanthera extract containing schisandrin A (7.25 mg), schisantherin A (7.33 mg) and schisandrol B (0.12 mg) twice daily for 13 days prior to tacrolimus administration.